Literature DB >> 28560811

Comparing the Effectiveness of Dynamic Treatment Strategies Using Electronic Health Records: An Application of the Parametric g-Formula to Anemia Management Strategies.

Yi Zhang1, Jessica G Young2, Mae Thamer1, Miguel A Hernán3,4.   

Abstract

OBJECTIVE: To compare the effectiveness of dynamic anemia management strategies by applying the parametric g-formula to electronic health records. DATA SOURCE/STUDY
SETTING: Patients with end-stage renal disease from the US Renal Data System who had congestive heart failure or ischemic heart disease and were undergoing hemodialysis in outpatient dialysis facilities between 2006 and 2010. STUDY
DESIGN: We explicitly emulated a target trial of three ‎erythropoietin dosing strategies (aimed at achieving a low, middle, or high hematocrit) and estimated the observational analog of the per-protocol effect.
RESULTS: Of 156,945 eligible patients, 41,970 died during the 18-month follow-up. Compared to the low-hematocrit strategy, the estimated risk of death was 4.6 (95% CI 4.4-4.9) percentage points higher under the high-hematocrit strategy and 1.8 (95% CI 1.7-1.9) percentage points higher under the mid-hematocrit strategy. The corresponding risk differences for a composite outcome of death and myocardial infarction were similar.
CONCLUSION: An explicit emulation of a target trial using electronic health records, combined with the parametric g-formula, allowed comparison of real-world dynamic strategies that have not been compared in randomized trials. © Health Research and Educational Trust.

Entities:  

Keywords:  Parametric g-formula; causal inference; comparative effectiveness research; target trial

Mesh:

Substances:

Year:  2017        PMID: 28560811      PMCID: PMC5980367          DOI: 10.1111/1475-6773.12718

Source DB:  PubMed          Journal:  Health Serv Res        ISSN: 0017-9124            Impact factor:   3.402


  27 in total

1.  When to start treatment? A systematic approach to the comparison of dynamic regimes using observational data.

Authors:  Lauren E Cain; James M Robins; Emilie Lanoy; Roger Logan; Dominique Costagliola; Miguel A Hernán
Journal:  Int J Biostat       Date:  2010       Impact factor: 0.968

2.  Estimating causal effects from epidemiological data.

Authors:  Miguel A Hernán; James M Robins
Journal:  J Epidemiol Community Health       Date:  2006-07       Impact factor: 3.710

3.  Beyond the intention-to-treat in comparative effectiveness research.

Authors:  Miguel A Hernán; Sonia Hernández-Díaz
Journal:  Clin Trials       Date:  2011-09-23       Impact factor: 2.486

4.  Using Big Data to Emulate a Target Trial When a Randomized Trial Is Not Available.

Authors:  Miguel A Hernán; James M Robins
Journal:  Am J Epidemiol       Date:  2016-03-18       Impact factor: 4.897

5.  US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States.

Authors:  Rajiv Saran; Yi Li; Bruce Robinson; John Ayanian; Rajesh Balkrishnan; Jennifer Bragg-Gresham; Joline T L Chen; Elizabeth Cope; Debbie Gipson; Kevin He; William Herman; Michael Heung; Richard A Hirth; Steven S Jacobsen; Kamyar Kalantar-Zadeh; Csaba P Kovesdy; Alan B Leichtman; Yee Lu; Miklos Z Molnar; Hal Morgenstern; Brahmajee Nallamothu; Ann M O'Hare; Ronald Pisoni; Brett Plattner; Friedrich K Port; Panduranga Rao; Connie M Rhee; Douglas E Schaubel; David T Selewski; Vahakn Shahinian; John J Sim; Peter Song; Elani Streja; Manjula Kurella Tamura; Francesca Tentori; Paul W Eggers; Lawrence Y C Agodoa; Kevin C Abbott
Journal:  Am J Kidney Dis       Date:  2015-07       Impact factor: 8.860

6.  Correction of anemia with epoetin alfa in chronic kidney disease.

Authors:  Ajay K Singh; Lynda Szczech; Kezhen L Tang; Huiman Barnhart; Shelly Sapp; Marsha Wolfson; Donal Reddan
Journal:  N Engl J Med       Date:  2006-11-16       Impact factor: 91.245

7.  Death, hospitalization, and economic associations among incident hemodialysis patients with hematocrit values of 36 to 39%.

Authors:  Allan J Collins; Suying Li; Wendy St Peter; Jim Ebben; Tricia Roberts; Jennie Z Ma; Willard Manning
Journal:  J Am Soc Nephrol       Date:  2001-11       Impact factor: 10.121

8.  The per-protocol effect of immediate versus deferred antiretroviral therapy initiation.

Authors:  Sara Lodi; Shweta Sharma; Jens D Lundgren; Andrew N Phillips; Stephen R Cole; Roger Logan; Brian K Agan; Abdel Babiker; Hartwig Klinker; Haitao Chu; Matthew Law; James D Neaton; Miguel A Hernán
Journal:  AIDS       Date:  2016-11-13       Impact factor: 4.177

9.  A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.

Authors:  Marc A Pfeffer; Emmanuel A Burdmann; Chao-Yin Chen; Mark E Cooper; Dick de Zeeuw; Kai-Uwe Eckardt; Jan M Feyzi; Peter Ivanovich; Reshma Kewalramani; Andrew S Levey; Eldrin F Lewis; Janet B McGill; John J V McMurray; Patrick Parfrey; Hans-Henrik Parving; Giuseppe Remuzzi; Ajay K Singh; Scott D Solomon; Robert Toto
Journal:  N Engl J Med       Date:  2009-10-30       Impact factor: 91.245

10.  Changes in fish consumption in midlife and the risk of coronary heart disease in men and women.

Authors:  Martin Lajous; Walter C Willett; James Robins; Jessica G Young; Eric Rimm; Dariush Mozaffarian; Miguel A Hernán
Journal:  Am J Epidemiol       Date:  2013-06-27       Impact factor: 4.897

View more
  12 in total

Review 1.  Contemporary use of real-world data for clinical trial conduct in the United States: a scoping review.

Authors:  James R Rogers; Junghwan Lee; Ziheng Zhou; Ying Kuen Cheung; George Hripcsak; Chunhua Weng
Journal:  J Am Med Inform Assoc       Date:  2021-01-15       Impact factor: 4.497

2.  The Relationship of Pain Reduction With Prevention of Knee Replacement Under Dynamic Intervention Strategies.

Authors:  S Reza Jafarzadeh; Tuhina Neogi; Daniel K White; David T Felson
Journal:  Arthritis Rheumatol       Date:  2022-09-01       Impact factor: 15.483

3.  Effects of Low-Flux and High-Flux Dialysis Membranes on Erythropoietin Responsiveness in Hemodialysis Patients.

Authors:  Walid A R Abdelhamid; Mohamed M Soliman; Ayman R A El-Hameed
Journal:  Int J Nephrol       Date:  2022-06-14

4.  Replicating Randomized Trial Results with Observational Data Using the Parametric g-Formula: An Application to Intravenous Iron Treatment in Hemodialysis Patients.

Authors:  Angelo Karaboyas; Hal Morgenstern; Nancy L Fleischer; Douglas E Schaubel; Bruce M Robinson
Journal:  Clin Epidemiol       Date:  2020-11-11       Impact factor: 4.790

5.  Causal inference on electronic health records to assess blood pressure treatment targets: an application of the parametric g formula.

Authors:  Kipp W Johnson; Benjamin S Glicksberg; Rachel A Hodos; Khader Shameer; Joel T Dudley
Journal:  Pac Symp Biocomput       Date:  2018

6.  A review of time scale fundamentals in the g-formula and insidious selection bias.

Authors:  Alexander P Keil; Jessie K Edwards
Journal:  Curr Epidemiol Rep       Date:  2018-06-15

7.  Parametric g-formula implementations for causal survival analyses.

Authors:  Lan Wen; Jessica G Young; James M Robins; Miguel A Hernán
Journal:  Biometrics       Date:  2020-07-06       Impact factor: 1.701

8.  Estimating Effects of Dynamic Treatment Strategies in Pharmacoepidemiologic Studies with Time-varying Confounding: A Primer.

Authors:  Xiaojuan Li; Jessica G Young; Sengwee Toh
Journal:  Curr Epidemiol Rep       Date:  2017-10-17

9.  Hypothetical blood-pressure-lowering interventions and risk of stroke and dementia.

Authors:  Liliana Paloma Rojas-Saunero; Saima Hilal; Eleanor J Murray; Roger W Logan; Mohammad Arfan Ikram; Sonja A Swanson
Journal:  Eur J Epidemiol       Date:  2020-11-27       Impact factor: 8.082

Review 10.  A scoping review of studies using observational data to optimise dynamic treatment regimens.

Authors:  Maarten J IJzerman; Julie A Simpson; Robert K Mahar; Myra B McGuinness; Bibhas Chakraborty; John B Carlin
Journal:  BMC Med Res Methodol       Date:  2021-02-22       Impact factor: 4.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.